Absorption Systems LP-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Absorption Systems LP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8010838
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月20日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Absorption Systems LP (Absorption Systems) is a pre-clinical contract research organization that develops and implements research tools. The organization carries out preclinical testing of drugs, biologics, and medical devices. It develops and implements research tools to predict human outcomes and overcome the absorption, distribution, metabolism, excretion and toxicology barriers. Absorption Systems provides services related to lead optimization, NDA-enabling, IND-enabling and bioanalysis. The organization also provides toxicology, compound characterization, pharmacokinetics, drug-drug interaction studies, GLP bioanalysis, and BCS testing, among others. It caters services to customers in the pharmaceutical, biotech and specialty CROs. Absorption Systems is headquartered in Exton, Pennsylvania, the US.

Absorption Systems LP – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Absorption Systems LP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Absorption Systems LP, Medical Devices Deals, 2011 to YTD 2017 8
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Absorption Systems LP, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Particle Sciences Enters Into An Agreement With Absorption Systems 10
Licensing Agreements 11
Absorption Systems Enters into Licensing Agreement with Pfizer 11
Absorption Systems Enters into Licensing Agreement with Pfizer 12
Acquisition 13
Absorption Systems Acquires TGA Sciences 13
Absorption Systems LP – Key Competitors 14
Absorption Systems LP – Key Employees 15
Absorption Systems LP – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Oct 11, 2017: Absorption Systems Expands its Presence in San Diego 17
Sep 27, 2017: Absorption Systems Announces Major Expansion of Facilities 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Absorption Systems LP, Pharmaceuticals & Healthcare, Key Facts 2
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Absorption Systems LP, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Absorption Systems LP, Medical Devices Deals, 2011 to YTD 2017 8
Absorption Systems LP, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Particle Sciences Enters Into An Agreement With Absorption Systems 10
Absorption Systems Enters into Licensing Agreement with Pfizer 11
Absorption Systems Enters into Licensing Agreement with Pfizer 12
Absorption Systems Acquires TGA Sciences 13
Absorption Systems LP, Key Competitors 14
Absorption Systems LP, Key Employees 15
Absorption Systems LP, Subsidiaries 16

★海外企業調査レポート[Absorption Systems LP-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Plymouth Rock Assurance Corporation:企業の戦略・SWOT・財務情報
    Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Plymouth Rock Assurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Sasol Ltd (SOL):石油・ガス:M&Aディール及び事業提携情報
    Summary Sasol Ltd (Sasol) is an integrated energy and chemicals company. It develops and commercializes technologies; and builds and operates facilities to produce a range of products, including liquid fuels, chemicals, and low-carbon electricity. The company’s product offerings include olefins and …
  • AeroParts Manufacturing & Repair, Inc:企業の戦略・SWOT・財務情報
    AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report Summary AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Dome Energy AB (DOME):石油・ガス:M&Aディール及び事業提携情報
    Summary Dome Energy AB (Dome Energy), formerly Commodity Quest AB is an oil and gas company that exploits, explores, develops and produces conventional oil and gas reserves. The company explores for onshore oil and gas fields to identify unexploited well locations. It explores and produces oil and g …
  • SI-Bone Inc (SIBN):医療機器:M&Aディール及び事業提携情報
    Summary SI-Bone Inc (SI-BONE) is a medical device company that develops, manufactures and distributes diagnosing and treating patients with SI joint disorders products and tools. The company offers medical devices for patients with low back issues, degenerative sacroiliitis, and SI joint disruptions …
  • Dance Biopharm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • PipeHawk Plc:企業の戦略・SWOT・財務分析
    PipeHawk Plc - Strategy, SWOT and Corporate Finance Report Summary PipeHawk Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Imperial Oil Ltd (IMO):企業の財務・戦略的SWOT分析
    Imperial Oil Ltd (IMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Aevis Victoria SA (AEVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Aevis Victoria SA (Aevis Victoria), a subsidiary of Medical Research, Services & Investments SA, is a diversified company that invests in healthcare, hospitality, telemedicine, life sciences and lifestyle. It owns and operates outpatient surgical centres, hospitals, medical network, and cent …
  • VentiRx Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary VentiRx Pharmaceuticals Inc (VentiRx) is a biopharmaceutical company that develops and commercializes drugs for the treatment of respiratory, autoimmune diseases and cancer. The company develops toll like receptor 8 agonist and antagonists for the treatment of cancer, respiratory and autoimm …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • EBOS Group Ltd (EBO):製薬・医療:M&Aディール及び事業提携情報
    Summary EBOS Group Ltd (EBOS) is a healthcare products supplier that markets, sells and distributes healthcare, medical and pharmaceutical products. It also markets and distributes animal care products and offers distribution, warehousing and logistics support to pharmaceutical manufacturers and med …
  • National Aerospace Fasteners Corporation:企業の戦略・SWOT・財務情報
    National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report Summary National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Colt Group Ltd:企業の戦略的SWOT分析
    Colt Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • House Foods Group Inc:企業の戦略・SWOT・財務分析
    House Foods Group Inc - Strategy, SWOT and Corporate Finance Report Summary House Foods Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • G M Breweries Ltd:企業の戦略・SWOT・財務分析
    G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gestamp Renewable Industries:電力:M&Aディール及び事業提携情報
    Summary Gestamp Renewable Industries, a subsidiary of Corporacion Gestamp SL, is a renewable energy service provider. The company offers development, promotion, construction and operation of electric generation power plants from biomass. It offers production, logistics, packaging, generation, design …
  • Amarillo Biosciences Inc (AMAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Amarillo Biosciences Inc (ABI) is a specialty biopharmaceutical company, which focuses on the development of biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of human disease indications such as influenza, hepatitis C, …
  • PT Charoen Pokphand Indonesia Tbk (CPIN):企業の財務・戦略的SWOT分析
    PT Charoen Pokphand Indonesia Tbk (CPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆